(Q34990610)

5 August 2017

1 reference

title

Measurement issues related to lipoprotein heterogeneity (English)

1 reference

5 August 2017

1 reference

1 reference

James D Otvos

1

1 reference

5 August 2017

Elias J Jeyarajah

series ordinal

2

1 reference

5 August 2017

William C Cromwell

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

American Journal of Cardiology

5 August 2017

1 reference

5 August 2017

90

1 reference

5 August 2017

8A

1 reference

5 August 2017

22i-29i

1 reference

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

The response-to-retention hypothesis of early atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Hypertriglyceridemia as a cardiovascular risk factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Apolipoprotein concentrations during treatment and recurrent coronary artery disease events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein B metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Lipoprotein correlates of LDL particle size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

An emerging understanding of the interactions of plasma lipoproteins with the arterial wall that leads to the development of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902632-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(02)02632-2

1 reference

release_zqyboqqxlrbm7npdjqx3bclwjy

5 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zqyboqqxlrbm7npdjqx3bclwjy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference